As of 2025-07-11, the EV/EBITDA ratio of Osprey Medical Inc (OSP.AX) is -0.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OSP.AX's latest enterprise value is 2.47 mil USD. OSP.AX's TTM EBITDA according to its financial statements is -9.74 mil USD. Dividing these 2 quantities gives us the above OSP.AX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 11.3x | 9.2x |
| Forward P/E multiples | 6.1x - 7.0x | 6.6x |
| Fair Price | (1.64) - (1.60) | (1.82) |
| Upside | -921.6% - -899.3% | -1010.9% |
| Date | EV/EBITDA |